Intravesical thermo-chemotherapy based on conductive heat: A first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients

Cancer Chemotherapy and Pharmacology

Volumn 73, Issue 3, 2014, Pages 503-509

  Milla, Paola ^a   Fiorito, Chiara ^a   Soria, Francesco ^a   Arpicco, Silvia ^a   Cattel, Luigi ^a   Gontero, Paolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bladder hyperthermia; Intravesical chemotherapy; Mitomycin C; Pharmacokinetics; Superficial transitional cell carcinoma

Indexed keywords

MITOMYCIN;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; BLADDER DISEASE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER PATIENT; CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTITIS; DRUG ABSORPTION; DRUG SCREENING; DRUG STABILITY; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTHERMIC THERAPY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; SIDE EFFECT; THERMAL CONDUCTIVITY; TRANSITIONAL CELL CARCINOMA; URETHRAL PAIN; URINARY FREQUENCY; URINARY URGENCY; URINE INCONTINENCE;

ADMINISTRATION, INTRAVESICAL; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 84896037923     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-014-2381-4     Document Type: Article

References (26)

1. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22(12):1435-1448 (Pubitemid 28550639)
2. Vogeli TA (2005) The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives. BJU Int 96(8):1171-1176. doi:10.1111/j.1464-410X.2005. 05928.x
3. Witjes JA, Hendricksen K (2008) Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol 53(1):45-52. doi:10.1016/j.eururo.2007.08.015 (Pubitemid 350167566)
4. Kaufman DS, Shipley WU, Feldman AS (2009) Bladder cancer. Lancet 374(9685):239-249. doi:10.1016/S0140-6736(09)60491-8
5. Shelley MD, Mason MD, Kynaston H (2010) Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treat Rev 36(3):195-205. doi:10.1016/j.ctrv.2009.12.005
6. Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester R, Burger M, Cowan N, Bohle A, Van Rhijn BW, Kaasinen E, Palou J, Shariat SF (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. doi:10.1016/j.eururo.2013.03.032
7. Lamm DL, Steg A, Boccon-Gibod L, Morales A, Hanna MG Jr, Pagano F, Alfthan O, Brosman S, Fisher HA, Jakse G et al (1989) Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications. Prog Clin Biol Res 310:335-355
8. Horvath A, Mostafid H (2009) Therapeutic options in the management of intermediate-risk nonmuscle-invasive bladder cancer. BJU Int 103(6):726-729. doi:10.1111/j.1464-410X.2008.08094.x
9. Bohle A, Jocham D, Bock PR (2003) Intravesical Bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol 169(1):90-95. doi:10.1097/01.ju.0000039680.90768.b3 (Pubitemid 35461559)
10. Dalbagni G (2007) The management of superficial bladder cancer. Nat Clin Pract Urol 4(5):254-260. doi:10.1038/ncpuro0784
11. Gwynn ES, Clark PE (2006) Bladder cancer. Curr Opin Oncol 18(3):277-283. doi:10.1097/01.cco.0000219258.75961.1a (Pubitemid 43740424)
12. Hendricksen K, Witjes JA (2007) Current strategies for first and second line intravesical therapy for nonmuscle invasive bladder cancer. Curr Opin Urol 17(5):352-357. doi:10.1097/MOU.0b013e3281c55f2b (Pubitemid 47351133)
13. Shen Z, Shen T, Wientjes MG, O'Donnell MA, Au JL (2008) Intravesical treatments of bladder cancer: review. Pharm Res 25(7):1500-1510. doi:10.1007/s11095-008-9566-7
14. Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R (2004) Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology 63(3):466-471. doi:10.1016/j.urology.2003.10.036
15. Lammers RJ, Witjes JA, Inman BA, Leibovitch I, Laufer M, Nativ O, Colombo R (2011) The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review. Eur Urol 60(1):81-93. doi:10.1016/j.eururo.2011.04.023
16. Rampersaud EN, Vujaskovic Z, Inman BA (2010) Hyperthermia as a treatment for bladder cancer. Oncology (Williston Park) 24(12):1149-1155
17. Colombo R, Da Pozzo LF, Salonia A, Rigatti P, Leib Z, Baniel J, Caldarera E, Pavone-Macaluso M (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21(23):4270-4276. doi:10.1200/JCO.2003.01.089 (Pubitemid 46621801)
18. Colombo R, Salonia A, Leib Z, Pavone-Macaluso M, Engelstein D (2010) Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU Int 107(6):912-918. doi:10.1111/j.1464-410X.2010.09654.x
19. Colombo R, Da Pozzo LF, Lev A, Salonia A, Rigatti P, Leib Z, Servadio C, Caldarera E, Pavone-Macaluso M (1998) Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors. J Urol 159(3):783-787 (Pubitemid 28106525)
20. Colombo R, Lev A, Da Pozzo LF, Freschi M, Gallus G, Rigatti P (1995) A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment. J Urol 153(3 Pt 2):959-963
21. Colombo R, Salonia A, Da Pozzo LF, Naspro R, Freschi M, Paroni R, Pavone-Macaluso M, Rigatti P (2003) Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: preliminary clinical experience. Crit Rev Oncol Hematol 47(2):127-139 (Pubitemid 36945311)
22. Paroni R, Salonia A, Lev A, Da Pozzo LF, Cighetti G, Montorsi F, Rigatti P, Colombo R (2001) Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br J Clin Pharmacol 52(3):273-278 (Pubitemid 33796224)
23. Joseph G, Biederbick W, Woschee U, Theisohn M, Klaus W (1997) Sensitive and convenient high-performance liquid chromatographic method for the determination of mitomycin C in human plasma. J Chromatogr B Biomed Sci Appl 698(1-2):261-267 (Pubitemid 27412529)
24. Dalton JT, Wientjes MG, Badalament RA, Drago JR, Au JL (1991) Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients. Cancer Res 51(19):5144-5152
25. Maffezzini M, Campodonico F, Manuputty EE, Puntoni M, Martelli A, Marini V, Tamagno S, Mattioli F (2013) Systemic absorption and pharmacokinetics of single-dose early intravesical mitomycin C after transurethral resection of non-muscle-invasive bladder cancer. Urology 82(2):400-404. doi:10.1016/j. urology.2013.03.036
26. Cordeiro ER, Geijsen DE, Zum Vorde Sive Vording PJ, Schooneveldt G, Sijbrands J, Hulshof MC, de la Rosette J, de Reijke TM, Crezee H (2013) Novel multisensor probe for monitoring bladder temperature during locoregional chemohyperthermia for nonmuscle-invasive bladder cancer: technical feasibility study. J Endourol 27(12):1504-1509. doi:10.1089/end 2013.0179